PureTech Health Continues $50M Share Buyback Program
Ticker: PTCHF · Form: 6-K · Filed: Feb 5, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Feb 5, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $50 million, $25 million |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: share-repurchase, capital-allocation, corporate-action
TL;DR
**PureTech is buying back $25M more of its own stock, which could boost share price.**
AI Summary
PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) announced on May 9, 2022, a $50 million share repurchase program for its ordinary shares. The program is split into two $25 million tranches, with the first completed on October 26, 2022. The second tranche is being executed through an agreement with Jefferies International Limited, which independently purchases shares on the London Stock Exchange. This matters to investors because share repurchases can reduce the number of outstanding shares, potentially increasing earnings per share and signaling management's confidence in the company's valuation.
Why It Matters
Share repurchases can boost shareholder value by reducing the number of outstanding shares, which often leads to higher earnings per share and a more attractive stock price.
Risk Assessment
Risk Level: low — Share repurchase programs are generally seen as a positive use of capital, indicating financial health and a commitment to shareholder returns.
Analyst Insight
A smart investor would view this as a positive signal, suggesting management believes the stock is undervalued and is committed to returning capital to shareholders. It might be a good time to hold or consider adding to a position, especially if other fundamentals are strong.
Key Numbers
- $50 million — Total Share Repurchase Program (The overall size of the program announced by PureTech Health plc.)
- $25 million — Value per Tranche (The amount allocated to each of the two equal parts of the repurchase program.)
- May 9, 2022 — Program Announcement Date (The date PureTech Health plc initially announced the share repurchase program.)
- October 26, 2022 — First Tranche Completion Date (The date the first half of the share repurchase program was successfully finished.)
Key Players & Entities
- PureTech Health plc (company) — the company executing the share repurchase program
- $50 million (dollar_amount) — total value of the share repurchase program
- May 9, 2022 (date) — when the share repurchase program was announced
- October 26, 2022 (date) — when the first tranche of the share repurchase program was completed
- Jefferies International Limited (company) — the firm executing the share purchases for PureTech
- $25 million (dollar_amount) — value of each tranche of the share repurchase program
Forward-Looking Statements
- PureTech Health's earnings per share will likely see a modest increase due to the reduced share count from the repurchase program. (PureTech Health plc) — medium confidence, target: Next earnings report
- The stock price of PureTech Health plc may experience upward pressure as the second tranche of the buyback program progresses. (PureTech Health plc) — medium confidence, target: Next 3-6 months
FAQ
What is the total value of PureTech Health plc's share repurchase program?
PureTech Health plc announced a $50 million share repurchase program for its ordinary shares.
When was the share repurchase program initially announced by PureTech Health plc?
The share repurchase program was announced on May 9, 2022.
How many tranches is the share repurchase program divided into, and what is the value of each?
The program is planned to be executed in two equal tranches, each for an aggregate consideration of no greater than $25 million.
Which firm is PureTech Health plc using to execute the share purchases for the second tranche?
PureTech Health plc entered into an irrevocable non-discretionary instruction with Jefferies International Limited for the purchase of Ordinary Shares.
On which stock exchange are the purchases for the second tranche of the program being carried out?
Any purchase of Ordinary Shares under the second tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed.
Filing Stats: 827 words · 3 min read · ~3 pages · Grade level 7.2 · Accepted 2024-02-05 16:30:33
Key Financial Figures
- $50 million — ompany) announced the commencement of a $50 million share repurchase program (the Program)
- $25 million — (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Or
Filing Documents
- d769656d6k.htm (6-K) — 27KB
- 0001193125-24-024099.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: February 5, 2024 By: /s/ Daphne Zohar Name: Daphne Zohar Title: Chief Executive Officer